b r i e f c o m m u n i c a t i o n s In a recent genome-wide association study of generalized vitiligo, we identified ten confirmed susceptibility loci. By testing additional loci that showed suggestive association in the genomewide study, using two replication cohorts of European descent, we observed replicated association of generalized vitiligo with variants at 3p13 encompassing FOXP1 (rs17008723, combined P = 1.04 × 10 −8 ) and with variants at 6q27 encompassing CCR6 (rs6902119, combined P = 3.94 × 10 −7 ).
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Generalized vitiligo is a common, complex autoimmune disease in which patchy depigmentation of skin and hair results from loss of melanocytes from involved areas 1 and which is epidemiologically associated with several other autoimmune diseases 2 . A number of potentially contributory genes have been suggested for generalized vitiligo on the basis of candidate gene association and genetic linkage studies, though few of these have received consistent support 3 .
We recently carried out a genome-wide association (GWA) study of individuals with generalized vitiligo, their families and controls, all of European descent, identifying ten different loci that contribute to generalized vitiligo risk 4 . In addition, seven other loci showed suggestive association with generalized vitiligo in the initial GWA analysis ( Supplementary Table 1 ), defined as nominal P values < 10 −4 for multiple SNPs clustered across a contiguous genomic region. At 3p13, we observed suggestive association of nine SNPs spanning nucleotides (nt) 71,505,650-71,571,667, of which the most significant was rs17008713 (P = 3.70 × 10 −6 , OR = 1.32), located within FOXP1 (Fig. 1a) . At 3q13.13, we observed suggestive association of 15 SNPs spanning nt 107,078,487-108,580,778; the most significant was rs2603127 (P = 2.69 × 10 −7 , OR = 1.34), located within MYH15. At 6q27, we observed suggestive association of 17 SNPs spanning nt 166,054,922-167,814,784; the most significant was rs6902119 (P = 5.72 × 10 −5 , OR = 1.21), upstream of CCR6 ( Fig. 1b) . At 7p21.3, we observed suggestive association of three SNPs spanning nt 8,176,301-8,185,089; the most significant was rs2192346 (P = 6.59 × 10 −5 , OR = 1.26), located within ICA1. At 9q22.33, we observed suggestive association of 10 SNPs spanning nt 100,951,838-101,049,252; the most significant was rs7868451 (P = 8.37 × 10 −5 , OR = 1.22), located within TBC1D2. At 12q13.2, we observed suggestive association of 6 SNPs spanning nt 56,368,078-56,491,880; the most significant was rs1701704 (P = 1.66 × 10 −7 , OR = 1.30), located upstream of IKZF4. At 12q24.12, we observed suggestive association of 18 SNPs spanning nt 110,557,312-113,039,943; the most significant was rs3184504 (P = 6.91 × 10 −6 , OR = 1.24), located within SH2B3.
To test replication of association of these seven candidate signals, we genotyped the most significant SNP in each locus (Supplementary Table 2 ) in two independent replication cohorts of European descent. Replication 1 consisted of 647 unrelated individuals with generalized vitiligo (cases) and 1,056 individuals without generalized vitiligo (controls; principally spouses of generalized vitiligo cases), and replication 2 consisted of 183 simplex generalized vitiligo trios and 332 generalized vitiligo multiplex families. rs17008713 could not be genotyped for technical reasons; accordingly, we imputed genotypes for the nearby SNP rs17008723 (imputed genotype r 2 = 0.995), which is in almost complete linkage disequilibrium (LD) with rs17008713 in the GWA dataset (r 2 = 0.99), and in the replication study, we genotyped rs17008723. SH2B3region SNP rs3184504 and IKZF4-region SNP rs1701704 deviated significantly from Hardy-Weinberg equilibrium in the replication 1 controls (P = 4.15 × 10 -17 and P = 2.92 × 10 -8 , respectively); therefore, these SNPs were excluded from further analysis. We calculated case-control association statistics using the Cochran-Armitage trend test implemented in PLINK 5 and calculated family-based association statistics using FBAT 6 . We carried out a combined meta-analysis of the two replication studies using a Cochran-Mantel-Haenszel test with cases and controls from replication 1 and cases and pseudocontrols derived from replication 2, and we carried out an overall combined meta-analysis of the two replication studies plus the GWA study. We considered as conservative joint criteria for confirmed association: (i) identification of the same high-risk allele in the GWA study and both of the replication studies; (ii) nominally significant (P < 0.05) association in both replication cohorts or significant association in one and marginal association in the other replication cohort; (iii) significant b r i e f c o m m u n i c a t i o n s (Bonferroni-corrected P < 1.0 × 10 −2 ; calculated as 0.05/5) combined replication stage 1 and 2 P value; and (iv) a genome-wide significant (P < 5 × 10 −8 ) 7 overall combined P value.
As shown in Table 1 , we replicated association for FOXP1-region SNP rs17008723 (risk allele G; combined replication stage 1 and 2 P = 1.36 × 10 −3 ; overall combined P = 1.04 × 10 −8 , OR = 1.33; Fig. 1a ) and for CCR6-upstream SNP rs6902119 (risk allele C; combined replication P = 3.79 × 10 −3 ; overall combined P = 3.94 × 10 −7 , OR = 1.23; Fig. 1b) , although the latter SNP did not achieve the genome-wide significance threshold in the combined analysis. MYH15 SNP rs2603127 showed a consistent high-risk allele across the three study cohorts and near genome-wide significant association in the combined analysis (P = 5.36 × 10 −8 ) but showed marginal or no association in the replication cohorts and marginal combined replication P values, and so was considered unconfirmed. SNPs at two loci, ICA1 and TBC1D2, failed to even show consistent high-risk alleles across the three study cohorts and thus are considered as most likely excluded for association with generalized vitiligo ( Supplementary Table 3 ). SNPs rs17008723, rs2603127 and rs6902119 were located at nt 71,573,135 in the FOXP1 region of 3p13; nt 167,505,791 in the CCR6 region of 6q27; and nt 108,243,551 in the MYH15 region of 3q13.13, respectively. SNP nucleotide positions are from GRCh37 and genes in close proximity to the designated SNP are denoted. AF RA , allele frequency of the risk allele. EIGENSTRAT GWA P values for SNPs rs17008723, rs6902119 and rs2603127 were 6.25 × 10 −6 , 7.23 × 10 −5 and 4.50 × 10 −7 , respectively. PLINK and EIGENSTRAT GWA test statistics were calculated and adjusted for the genomic inflation factor 1.048 as described in the supplementary methods. The Bonferroni-adjusted significance threshold for the combined replication stage 1 + 2 meta-analysis was P < 1.00 × 10 −2 , and the significance threshold for the overall combined GWA + replication stage 1 + 2 meta-analysis was P < 5 × 10 −8 . FOXP1 SNP rs17008713 from the GWA study could not be genotyped in the replication study for technical reasons; therefore, genotypes for nearby SNP rs17008723 (r 2 = 0.99) were imputed and rs17008723 was genotyped in the replication study. Data for SNPs rs2192346 and rs7868451, for which association was excluded, are shown in supplementary table 3.
FOXP3 and CCR6 both encode proteins that play important roles in immune regulation. FOXP1 encodes a widely expressed transcription factor that is essential for the development of B cells 8 , quiescent naive T cells 9 and monocytes 10 , and it is paralogous to FOXP3, which encodes a transcriptional regulator of regulatory T-cell development and function and is the defective gene in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) multiple autoimmune disease syndrome 11 . Foxp1 conditional knockout mice have premature cell-autonomous hyper-activation of early thymocytes to CD4 + and CD8 + mature T cells with effector functions 9 .
CCR6 encodes a receptor for macrophage inflammatory protein-3a (CCL20) that is expressed in unactivated memory B and T cells, T helper 17 cells and some dendritic cells and that plays a key role in B-cell differentiation and tissue-specific migration of dendritic and T cells during inflammatory and immunological responses 12 . Another CCR6 SNP, rs2301436, has been associated with inflammatory bowel disease 13 , with the same high-risk allele as that observed in the generalized vitiligo GWA dataset (P = 2.27 × 10 −4 ). SNPs rs6902119 and rs2301436 are in moderate LD (r 2 = 0.64), and logistic regression analysis indicated that association of generalized vitiligo with rs2301436 might be secondary to its LD with rs6902119 (P = 0.0712). Recently, we described a small GWA study of generalized vitiligo in an isolated Romanian founder population 14 and identified association in that group with another SNP in 6q27, rs13208776, located 1.44 Mb distal to rs6902119 within SMOC2. We found no association between generalized vitiligo and SNPs in the vicinity of rs13208776 in the present study and no apparent longrange LD between rs6902119 and rs13208776 (r 2 = 0); nevertheless, we cannot exclude the possibility that in the Romanian founder population, a variant near rs13208776 might influence expression of CCR6 from a distance. Notably, these vitiligo-associated 6q27 SNPs are in close proximity to IDDM8 (see URLs), a locus with linkage and association with type I diabetes and rheumatoid arthritis 15 , autoimmune diseases that are epidemiologically associated with generalized vitiligo 2 .
Our findings provide additional evidence that variation in genes encoding proteins with roles in the immune system contribute to susceptibility to generalized vitiligo. Moreover, many of these genes also contribute to other autoimmune diseases, particularly those with which generalized vitiligo is epidemiologically associated. Although each of the generalized vitiligo susceptibility loci thus far identified accounts for only a small increase in relative risk, the biological pathways they highlight provide insights into the pathogenesis of generalized vitiligo and other autoimmune diseases and may afford relatively tractable targets for therapeutic intervention.
URL. IDDM8, http://www.t1dbase.org/.
metHoDs Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
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